β Scribed by Sudhir Isharwal; Zhou Wang
No coin nor oath required. For personal study only.
Prostate cancer (PCa) is a disease with high incidence and prevalence. Early detection of PCa has been an area for research to decrease its morbidity and mortality. The discovery of prostate specific antigen (PSA) revolutionized screening of PCa, which was largely dependent on detection of prostatic acid phosphatase and digital rectal examination. Several leading organizations and cancer societies, based on present evidence, have published their recommendations for its use in detection and monitoring of PCa. There has been difference in opinions on its appropriate threshold value to recommend prostate biopsy and benefits on health outcomes due to its use in screening. This new book presents and discusses current research in the study of PCa and it's role in the screening of prostate cancer.
Prostate -- Cancer -- Diagnosis. ; Prostate-specific antigen.
π SIMILAR VOLUMES
Northwest Prostate Institute, Seattle, WA. Text covers the history of prostate specific antigen, biochemistry, variability of immunoassays for PSA, PSA density, PSA velocity, age-specific PSA, free and total PSA, early detection, repeat biopsy, alpha-1-antichymotrypsin, staging, radical prostatectom
This state-of-the-art reference provides a comprehensive review of prostate specific antigen (PSA) and related prostate markers-examining velocity, density, and age-specific reference ranges for increased sensitivity in PSA tumor identification and selection of patient therapies. Supplemented with
This state-of-the-art reference provides a comprehensive review of prostate specific antigen (PSA) and related prostate markers-examining velocity, density, and age-specific reference ranges for increased sensitivity in PSA tumor identification and selection of patient therapies. Supplemented with
<p>Prostate cancer treatment dates back almost treatment approaches is examined in the subse- 100years. However, in an era of rapid develop- quent chapters of this volume. ments and innovations in cancer research and Te text addresses the time-honoured h- uro-oncology, there is an increasing need to
<p>In February 1980 the Royal College of Radiologists, London, held its Second Symposium on Clinical Oncology. The subject was Prostatic Cancer and this publication is based on the presenΒ tations at this meeting by leading authorities in the United Kingdom. The principal objective of these Symposia
<p>This issue of Radiation Medicine Rounds examines the latest advances in the use of radiation medicine in treatment of prostate cancer Prostate cancer is the most common cancer in males and radiation therapy is a major tool in the management of the disease. This issue of Radiation Medicine Rounds